Pasithea Therapeutics logo

Pasithea Therapeutics Share Price Today

(NASDAQ: KTTA)

Pasithea Therapeutics share price is $1.65 & ₹141.00 as on 26 Apr 2025, 2.30 'hrs' IST

$1.65

-0.07

(-4.07%)

Live

View live Pasithea Therapeutics share price in Dollar and Rupees. Guide to invest in Pasithea Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pasithea Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Pasithea Therapeutics share price movements

  • Today's Low: $1.60
    Today's High: $1.76

    Day's Volatility :9.09%

  • 52 Weeks Low: $0.92
    52 Weeks High: $7.69

    52 Weeks Volatility :88.0%

Pasithea Therapeutics (KTTA) Returns

PeriodPasithea Therapeutics CorpIndex (Russel 2000)
3 Months
-29.51%
0.0%
6 Months
-53.51%
0.0%
1 Year
-76.24%
0.0%
3 Years
-92.59%
-9.5%

Pasithea Therapeutics (KTTA) Key Statistics

in dollars & INR

Previous Close
$1.72
Open
$1.76
Today's High
$1.76
Today's Low
$1.6
Market Capitalization
$4.4M
Today's Volume
$284.0K
52 Week High
$7.69
52 Week Low
$0.9226
Revenue TTM
$486.6K
EBITDA
$-13.6M
Earnings Per Share (EPS)
$-13.35
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-72.84%

How to invest in Pasithea Therapeutics Stock (KTTA) from India?

It is very easy for Indian residents to invest directly in Pasithea Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pasithea Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pasithea Therapeutics or KTTA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pasithea Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pasithea Therapeutics shares which would translate to 0.518 fractional shares of Pasithea Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pasithea Therapeutics, in just a few clicks!

Returns in Pasithea Therapeutics (KTTA) for Indian investors in Rupees

The Pasithea Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pasithea Therapeutics investment value today

Current value as on today

₹25,365

Returns

₹74,635

(-74.63%)

Returns from Pasithea Therapeutics Stock

₹77,210 (-77.21%)

Dollar Returns

₹2,575 (+2.58%)

Indian investors sentiment towards Pasithea Therapeutics (KTTA)

4200.0%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Investment in Pasithea Therapeutics Shares from India has grown by 4200.0% over the past 30 days, indicating increased transactional activity.

1700%

Period: Mar 25, 2025 to Apr 24, 2025. Change in 30 Days versus previous period

Search interest for Pasithea Therapeutics Stock from India on INDmoney has increased by 1700% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Pasithea Therapeutics

  • Armistice Capital, LLC

    2.25%

  • UBS Group AG

    0.48%

  • Tower Research Capital LLC

    0.07%

  • Morgan Stanley - Brokerage Accounts

    0.04%

  • Royal Bank of Canada

    0.01%

  • JPMorgan Chase & Co

    0.01%

Analyst Recommendation on Pasithea Therapeutics

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pasithea Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Pasithea Therapeutics Stock (KTTA)

What analysts predicted

Upside of 21.21%

Target:

$2.00

Current:

$1.65

Insights on Pasithea Therapeutics Stock (Ticker Symbol: KTTA)

  • Price Movement

    In the last 7 days, KTTA stock has moved up by 24.6%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 13.58K → 976.30K (in $), with an average increase of 59.4% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -2.99M → -3.17M (in $), with an average decrease of 5.9% per quarter
  • KTTA vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 72.4% return, outperforming this stock by 148.6%
  • KTTA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 57.3% return, outperforming this stock by 149.9%
  • Price to Sales

    ForKTTA every $1 of sales, investors are willing to pay $4.6, whereas for Beone Medicines Ltd, the investors are paying $7.1 for every $1 of sales.

Pasithea Therapeutics Technicals Summary

Sell

Neutral

Buy

Pasithea Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pasithea Therapeutics (KTTA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pasithea Therapeutics Corp logo
24.64%
-53.51%
-76.24%
-92.59%
-97.58%
Regeneron Pharmaceuticals, Inc. logo
-6.31%
-35.72%
-32.66%
-11.12%
9.54%
Beone Medicines Ltd logo
2.09%
20.37%
72.43%
67.9%
55.25%
Vertex Pharmaceuticals Incorporated logo
-1.56%
3.09%
23.83%
83.97%
83.41%
Alnylam Pharmaceuticals, Inc. logo
-9.88%
-14.83%
68.82%
56.52%
70.01%

About Pasithea Therapeutics

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Organization
Pasithea Therapeutics
Employees
4
CEO
Dr. Tiago Reis Marques M.D., Ph.D.
Industry
Miscellaneous

Management People of Pasithea Therapeutics

NameTitle
Dr. Lawrence Steinman BA, M.D., Ph.D.
Co-Founder, MD & Executive Chairman
Dr. Tiago Reis Marques M.D., Ph.D.
CEO & Director
Mr. Daniel H. Schneiderman
Chief Financial Officer

Important FAQs about investing in KTTA Stock from India :

What is Pasithea Therapeutics share price today?

Pasithea Therapeutics share price today stands at $1.65, Open: $1.64 ; Previous Close: $1.72 ; High: $1.76 ; Low: $1.60 ; 52 Week High: $7.69 ; 52 Week Low: $0.92.

The stock opens at $1.64, after a previous close of $1.72. The stock reached a daily high of $1.76 and a low of $1.60, with a 52-week high of $7.69 and a 52-week low of $0.92.

Can Indians buy Pasithea Therapeutics shares?

Yes, Indians can invest in the Pasithea Therapeutics (KTTA) from India.

With INDmoney, you can buy Pasithea Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pasithea Therapeutics at zero transaction cost.

How can I buy Pasithea Therapeutics shares from India?

It is very easy to buy Pasithea Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pasithea Therapeutics (KTTA) be purchased?

Yes, you can buy fractional shares of Pasithea Therapeutics with INDmoney app.

What are the documents required to start investing in Pasithea Therapeutics stocks?

To start investing in Pasithea Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pasithea Therapeutics Stock (KTTA)?

Today’s highest price of Pasithea Therapeutics (KTTA) is $1.76.

Today’s lowest price of Pasithea Therapeutics (KTTA) is $1.60.

What is today's market capitalisation of Pasithea Therapeutics?

Today's market capitalisation of Pasithea Therapeutics KTTA is 4.4M

What is the 52 Week High and Low Range of Pasithea Therapeutics Stock (KTTA)?

  • 52 Week High

    $7.69

  • 52 Week Low

    $0.92

What are the historical returns of Pasithea Therapeutics (KTTA)?

  • 1 Month Returns

    24.64%

  • 3 Months Returns

    -53.51%

  • 1 Year Returns

    -76.24%

  • 5 Years Returns

    -97.58%

Who is the Chief Executive Officer (CEO) of Pasithea Therapeutics ?

Dr. Tiago Reis Marques M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pasithea Therapeutics.